Sponsor Dossier
Proqualix Pty Ltd - in Administration
Sponsor Dossier for Proqualix Pty Ltd - in Administration. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALDACTONE
- Brand: Aldazide
- Brand: CYTOTEC
- Brand: DIULO Tablets
- Brand: DRAMAMINE
- Brand: FEMULEN
- Brand: FLORAQUIN
- Brand: IONAMIN
About
Proqualix Pty Ltd — in Administration is an Australian Private Company with ABN 49091736104, based in New South Wales, with an entity status of Cancelled.
Portfolio
Proqualix maintains a portfolio of 19 brands on the ARTG, with 1 indexable brand and 1 brand with at least one PBS-listed item. Notable brands include ALDACTONE, Aldazide, CYTOTEC, DIULO Tablets, DRAMAMINE, FEMULEN, FLORAQUIN, IONAMIN, LOMOFEN, LOMOTIL, Lotussin and MAXAQUIN.
Therapeutic focus —
Gastroenterology: 4 brands — Cardiology: 4 brands — Infectious Disease: 3 brands — Respiratory: 2 brands — Reproductive Health: 2 brands — Complementary Medicine: 1 brand — Neurology: 1 brand — Endocrinology: 1 brand — Psychiatry: 1 brand
PBS footprint
One brand in the portfolio has at least one PBS-listed item, with the latest PBS schedule date touched on 1 May 2026.